Future experiments are needed to explore further genetic alterations or risk factors predominantly associated with female HCC in patient stratification, such as Bap1 mutations or malignant transformation of hepatocellular adenomas4,36. This evidence concerns the gene BAP1 and hepatocellular carcinoma.